RLS (USA) INC.

RLS (USA) INC. specializes in the manufacturing of radiopharmaceuticals and associated pharmaceutical preparations for federal healthcare and defense systems. The company’s core capabilities center on the aseptic production, quality control, and supply chain logistics of diagnostic and therapeutic radiopharmaceuticals, including isotopes such as technetium-99m and fluorodeoxyglucose, used in nuclear medicine imaging and targeted radiotherapy. Their technical expertise includes compliance with current Good Manufacturing Practices (cGMP), radiological safety protocols, and the handling of short-half-life radionuclides under strict regulatory oversight. RLS (USA) INC. differentiates itself through consistent delivery of mission-critical radiopharmaceuticals to high-acuity clinical environments, ensuring timely, sterile, and isotopically pure products for patient care. The contractor maintains a primary relationship with the Department of Veterans Affairs, supplying radiopharmaceuticals and related supplies to VA medical centers nationwide, particularly for nuclear imaging programs at facilities such as the Northern California Health Care System. Their work supports VA’s mission to deliver advanced diagnostic services to veteran populations. Limited engagement with the Department of Defense suggests ancillary support for military medical operations requiring on-site radiopharmaceutical availability. Operating under NAICS 325412, RLS (USA) INC. is positioned within the pharmaceutical preparation manufacturing sector, with a sharp vertical specialization in nuclear medicine. Their market focus is narrow and highly technical, serving institutions requiring reliable, FDA-regulated radiopharmaceutical production under controlled radiation environments. As a 2L entity based in Lake Mary, Florida, RLS (USA) INC. operates as a mid-sized manufacturer without federal certifications such as 8(a), HUBZone, or small business status. The company’s geographic footprint is centered on Florida, but its supply chain extends nationally to serve VA and DoD medical facilities. Its government market positioning is defined by reliability in a niche, high-regulation segment critical to patient diagnostics and therapeutic outcomes.